10-QPeriod: Q3 FY2021

MICROCHIP TECHNOLOGY INC Quarterly Report for Q3 Ended Dec 31, 2020

Filed February 4, 2021For Securities:MCHPMCHPP

Summary

Microchip Technology Inc. reported its third-quarter fiscal year 2021 results ending December 31, 2020. The company demonstrated resilience with a 5.0% increase in net sales for the quarter to $1.35 billion, compared to the prior year, driven by strength in its microcontroller and analog product lines. For the nine-month period, net sales saw a modest 0.6% increase to $3.97 billion. Gross profit margin improved to 62.6% in the quarter from 61.0% in the prior year, reflecting better capacity utilization and product mix. The company also managed operating expenses effectively, with R&D and SG&A expenses as a percentage of sales decreasing year-over-year. Despite ongoing supply chain constraints expected to persist through most of calendar year 2021, Microchip's cash flow from operations remained robust, providing ample liquidity. The company continues to invest in its long-term strategy, focusing on embedded control solutions and total system solutions. Significant debt management activities were undertaken, including the settlement of convertible debt and issuance of new senior notes. While facing market uncertainties and supply chain challenges, Microchip's strategic focus and financial discipline position it to navigate the current environment.

Financial Statements
Beta
Revenue$1.35B
Cost of Revenue$506.30M
Gross Profit$845.80M
R&D Expenses$210.10M
SG&A Expenses$154.20M
Operating Expenses$600.20M
Operating Income$245.60M
Interest Expense$86.50M
Net Income$36.20M
EPS (Basic)$0.07
EPS (Diluted)$0.07
Shares Outstanding (Basic)526.80M
Shares Outstanding (Diluted)550.80M

Key Highlights

  • 1Net sales increased 5.0% year-over-year to $1.35 billion in the third quarter, driven by strong microcontroller and analog product performance.
  • 2Gross profit margin improved to 62.6% in the quarter, up from 61.0% in the prior year, reflecting improved operational efficiency and product mix.
  • 3Operating expenses as a percentage of net sales decreased for both R&D (15.5% vs. 16.9%) and SG&A (11.4% vs. 13.3%) compared to the prior year's quarter.
  • 4Cash flow from operating activities was strong, totaling $1.47 billion for the nine-month period, demonstrating healthy cash generation.
  • 5The company is experiencing supply chain constraints, which are expected to continue through most of calendar year 2021, impacting lead times.
  • 6Significant debt management activities were executed, including convertible debt settlements and the issuance of new senior notes, leading to a reduction in interest expense.
  • 7The company declared a quarterly cash dividend of $0.3685 per share, continuing its commitment to returning value to shareholders.

Frequently Asked Questions